Ventas Inc
NYSE: VTR · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-04-30
Ventas Inc (VTR) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
Ventas announced an expanded senior housing investment pipeline expected to exceed $2.5 billion in 2026, with Q4 2025 results showing 15% same-store NOI expansion in their Senior Housing Operating Portfolio and 8% normalized FFO per share growth. Management approved an 8% quarterly dividend increase, signaling confidence in forward cash generation and growth trajectory.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.9B | $5.8B | $6.6B | $7.3B | $8.0B | $8.8B | $9.6B |
| Revenue growth | — | 9.5% | 18.5% | 13.7% | 10.1% | 10.1% | 9.5% | 9.1% |
| EPS | $-0.19 | $0.20 | $0.50 | $0.71 | $1.11 | $1.42 | $1.68 | $1.95 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $166.54 | $183.19 | $199.85 | $224.83 | $241.48 |
Catalysts & risks
Methodology
Ventas Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 13 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.